OR-LATTICE-SEMICONDUCTOR
24.6.2020 22:02:04 CEST | Business Wire | Press release
Lattice Semiconductor Corporation (NASDAQ: LSCC), the low power programmable leader, today launched the new Lattice Certus™-NX family of FPGAs. The devices lead the general-purpose FPGA market in I/O density, delivering up to twice the I/O density per mm2 in comparison to similar competing FPGAs, and provide best-in-class power savings, small size, reliability, instant-on performance, and support fast PCI Express (PCIe) and Gigabit Ethernet interfaces to enable data co-processing, signal bridging, and system control. Certus-NX FPGAs target a range of applications, from data processing in automated industrial equipment to system management in communications infrastructure. The Certus-NX devices are the second family of FPGAs developed on the Lattice Nexus™ platform, the industry’s first low power FPGA platform using 28 nm FD-SOI process technology. With the launch of Certus-NX, Lattice marks the release of the second device family developed under Lattice’s new product development strategy in just six months.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200624005722/en/
“Certus-NX delivers unique and innovative capabilities that set it apart,” said Linley Gwennap, Principal Analyst at The Linley Group. “Compared to competing FPGAs of similar gate counts, Lattice offers a much smaller package, greater I/O density, and lower power.”
“Thanks to innovations at the system, architecture, and circuit level in our Lattice Nexus development platform, we are releasing new products at a faster pace and giving our customers more options to choose from as they evaluate the performance and power needs of their applications,” said Gordon Hands, Director of Product Marketing, Lattice Semiconductor. “Certus-NX has clearly reset expectations for what developers should look for in general-purpose FPGAs by providing a compelling blend of parallel processing performance and flexible I/O support that enables creative new device designs.”
Technology trends like industrial automation and 5G have developers across markets looking to add processing and connectivity to applications that operate at the network Edge. To successfully support these trends, devices require low power processing hardware with support for popular interfaces like PCIe and Gigabit Ethernet. Device developers also need easy-to-use development platforms from a single source that provide the hardware, software, and IP they need to get products to market quickly.
“As an FPGA-centric design house, we’re seeing increasing adoption of serial protocols like PCIe and Gigabit Ethernet for chip-to-chip connectivity in many end applications, including 5G and IoT systems,” said Sanjeev Kumar, CEO, Logic Fruit Technologies. “The latest generation of FPGAs by Lattice, Certus-NX, supports these standards and provides a high density of I/Os while keeping power consumption and overall device footprint in check. These FPGAs will allow us to rapidly adapt to the challenging and evolving connectivity and performance needs of our customers.”
Key features of the Lattice Certus-NX FPGA family include:
- Up to 3x smaller form factor – Certus-NX FPGAs easily fit into compact designs with minimal impact on overall design footprint. For example, Certus-NX FPGAs can enable a complete PCIe solution with a size of only 36 mm2 . Even when using the smallest package available in the family, Certus-NX FPGAs deliver up to twice the I/O density per mm2 in comparison to similar competing FPGAs to enable greater design flexibility and robust support for bridging applications.
-
Robust I/O interfacing capability – Certus-NX developers will have access to Lattice’s extensive IP library. Notable IP blocks available on Certus-NX include:
- 1.5 Gbps differential I/O with performance that is up to 70 percent higher than competing FPGAs.
- 5 Gbps PCIe, 1.5 Gbps SGMII, and 1066 Mbps DDR3. Developers can test these IP blocks on Certus-NX development boards for the fast implementation of interfaces commonly used in Certus-NX FPGAs’ target applications.
-
Robust authentication and encryption – To secure the devices’ bitstream against unauthorized access/alteration/copying, Certus-NX FPGAs support AES-256 with ECDSA authentication to protect devices throughout their lifecycles. Currently, Certus-NX devices are the smallest FPGAs on the market to support ECDSA.
- Up to 4x lower power consumption – Certus-NX FPGAs use a programmable back bias to enable user-selectable high performance or low power operating modes, depending on the needs of their application. The devices can provide power consumption up to 4x lower than similar FPGAs.
- Instant-on performance – The devices also offer ultra-fast device configuration from SPI memory that is up to 12x faster than similar competing FPGAs, with individual I/Os able to configure in just 3 ms, and full-device startup in only 8-14 ms depending on device capacity.
- High reliability – Reliable performance is key for safety-critical industrial and automotive applications where devices must perform as expected to avoid damage/injury. Certus-NX FPGAs offer up to 100 times better soft-error rate (SER) performance than similar FPGAs. Certus-NX FPGAs are temperature-rated for use in industrial applications. They also support ECC and SEC in hardware.
- Ease of use/design – Certus-NX FPGAs support Lattice Radiant® software, an easy-to-use, unified FPGA design environment that integrates best-in-class tools and features to help users develop their applications quickly and efficiently.
Lattice has already shipped sample devices to select customers. For more information, please visit http://www.latticesemi.com/Certus-NX .
About Lattice Semiconductor
Lattice Semiconductor (NASDAQ: LSCC) is the low power programmable leader. We solve customer problems across the network, from the Edge to the Cloud, in the growing communications, computing, industrial, automotive, and consumer markets. Our technology, long-standing relationships, and commitment to world-class support lets our customers quickly and easily unleash their innovation to create a smart, secure and connected world.
For more information about Lattice, please visit www.latticesemi.com . You can also follow us via LinkedIn , Twitter , Facebook , YouTube , WeChat , Weibo or Youku .
Lattice Semiconductor Corporation, Lattice Semiconductor (& design) and specific product designations are either registered trademarks or trademarks of Lattice Semiconductor Corporation or its subsidiaries in the United States and/or other countries. The use of the word “partner” does not imply a legal partnership between Lattice and any other entity.
GENERAL NOTICE: Other product names used in this publication are for identification purposes only and may be trademarks of their respective holders.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200624005722/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex to Present New Data on ALYFTREK® at the North American Cystic Fibrosis Conference9.10.2026 19:15:00 CEST | Press release
- Data on ALYFTREK in children ages 2 to 5 years demonstrate recovery of pancreatic function in some children –- Additional abstracts on clinical and real-world evidence on CFTR modulators also presented - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) 2 to 5 years old open-label extension study, highlighting recovery of exocrine pancreatic function in some children in that age group, allowing those children to discontinue pancreatic enzyme replacement therapy (PERT). Pancreatic exocrine insufficiency in children with cystic fibrosis (CF) was previously believed to be irreversible. These data were presented at the North American Cystic Fibrosis Conference (NACFC). “The data presented at NACFC underscore the safety and efficacy of our CF medicines in the real world and in clinical trials in younger age groups. The data from the Phase 3 open-label study in 2 to 5 year olds evaluating exocrine p
Andersen Consulting udvider med TalentSmartEQ for at fremme lederskab og virksomhedstransformation9.10.2026 18:48:00 CEST | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for humankapital gennem en samarbejdsaftale med TalentSmartEQ, en San Diego-baseret virksomhed, der har fokus på at skabe praktiske, engagerende og handlingsorienterede læringsoplevelser med udgangspunkt i emotionel intelligens (EQ) og lederudvikling. I mere end to årtier har TalentSmartEQ arbejdet sammen med organisationer verden over med henblik på at udvikle ledelseskompetencer ved hjælp af emotionel intelligens og dermed styrke medarbejderengagement, teamwork og de samlede resultater. Virksomheden kombinerer forskningsbaserede metoder med praktiske læringsforløb, vurderinger, coaching og skræddersyede programmer, der skal omsætte opbygningen af emotionel intelligens til vedvarende ændringer i adfærden på arbejdspladsen. Som førende aktør i branchen samarbejder TalentSmartEQ med organisationer lige fra Fortune 500-virksomheder til offentlige myndigheder og privatejede virksomheder. "Organisationer stiller stadig større krav til dere
Verdant Rock Receives A (low) Financial Strength Rating from Morningstar DBRS, Adding a Second International Investment-Grade Assessment9.10.2026 16:00:00 CEST | Press release
Verdant Rock now holds Financial Strength Ratings from both Fitch Ratings and Morningstar DBRS, providing counterparties with dual-agency confirmation and reinforcing the security architecture behind each financial guarantee Verdant Rock Limited, a Bermuda Monetary Authority-regulated Class 3B insurance company, has received an A (low) Financial Strength Rating from Morningstar DBRS. The rating reflects Verdant Rock’s financial strength and its capacity to meet policyholder obligations as an investment-grade financial guarantor for Emerging Markets credit. Morningstar DBRS is a global credit rating agency with coverage across North America, Europe, Asia, and Latin America. Its assessment of Verdant Rock reflects the company’s strong projected earnings ability, robust risk profile, sound liquidity, and good capitalization. Morningstar DBRS also assigned an A (low) Issuer Rating to Verdant Rock. The rating follows Verdant Rock’s BBB+ Long-Term Insurer Financial Strength Rating with a Sta
Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions9.10.2026 15:17:00 CEST | Press release
We think Gartner recognizes Tecnotree's open, governed approach to agentic AI as operators make AI the engine of their revenue operations Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, today announced that Gartner has positioned it as a Visionary in the first-ever Magic Quadrant for AI-Enabled CSP Marketing and Sales Solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261009905430/en/ Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions A new category for a new operating model. CSPs are fighting saturated markets, rising acquisition costs, and accelerating churn. They are responding with AI-driven automation across the full revenue cycle, from segmentation and campaigns to lead management, CPQ, and renewals, increasingly executed by autonomous agents. According to us, Gartner creation of this Magi
Positive New Data on Corcym’s Perceval Plus Sutureless Aortic Heart Valve Encompasses up to 7-Year Follow-up9.10.2026 15:15:00 CEST | Press release
Data Presented at Annual Meeting of European Association for Cardio-Thoracic Surgery (EACTS), Along with 6 Perceval Plus E-PostersEACTS Also Marks Commercial Launch of TriMemo and Memo 4D Curve, Innovative Repair Devices for Tricuspid and Mitral Valves Corcym, a global medical device company dedicated to cardiac surgery, today announced that positive mid-term data from a sub-analysis of its Perceval Plus sutureless aortic heart valve as part of its MANTRA clinical trial was featured in an oral presentation today at the annual meeting of the European Association for Cardio-Thoracic Surgery (EACTS). The study is the longest follow-up available for Perceval Plus and the FREE tissue treatment from an international multicenter study, and demonstrated excellent durability, safety and quality of life improvements. Perceval Plus is the only sutureless and collapsible aortic surgical heart valve. Its unique design performs in any surgical scenario and is optimal for endoscopy and robotics. The
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
